TY - JOUR
T1 - Microbiome genomics for cancer prediction
AU - Adlung, Lorenz
AU - Elinav, Eran
AU - Greten, Tim F.
AU - Korangy, Firouzeh
N1 - L.A. received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie Grant Agreement No. 842203. E.E. is the incumbent of the Sir Marc and Lady Tania Feldmann Professorial Chair, a senior fellow at the Canadian Institute of Advanced Research (CIFAR) and an international scholar at the Bill & Melinda Gates Foundation and the Howard Hughes Medical Institute. T.F.G. is supported by the Intramural Research Program of the NIH, NCI (ZIA BC 011344).
PY - 2020/4/20
Y1 - 2020/4/20
N2 - Although cancer genomics is a powerful tool to understand cancer and develop diagnostic tools, the contribution of the microbiome in cancer diagnosis and clinical assessment is much less studied. Elinav, Greten and colleagues provide their respective views on how studying cancer metagenomes could facilitate identification, diagnosis and staging of different tumor types.
AB - Although cancer genomics is a powerful tool to understand cancer and develop diagnostic tools, the contribution of the microbiome in cancer diagnosis and clinical assessment is much less studied. Elinav, Greten and colleagues provide their respective views on how studying cancer metagenomes could facilitate identification, diagnosis and staging of different tumor types.
UR - https://www.scopus.com/pages/publications/85100846843
U2 - 10.1038/s43018-020-0059-x
DO - 10.1038/s43018-020-0059-x
M3 - Article
SN - 1474-175X
VL - 1
SP - 379
EP - 381
JO - Nature Reviews Cancer
JF - Nature Reviews Cancer
IS - 4
ER -